Literature DB >> 33840225

Divergent Functions of Tissue-Resident and Blood-Derived Macrophages in the Hemorrhagic Brain.

Che-Feng Chang1,2, Brittany A Goods3, Michael H Askenase2,4, Hannah E Beatty2,4, Artem Osherov2, Jonathan H DeLong2,4, Matthew D Hammond2, Jordan Massey2, Margaret Landreneau2, J Christopher Love3, Lauren H Sansing2,4.   

Abstract

Background and Purpose: Brain tissue-resident microglia and monocyte-derived macrophages (MDMs) are innate immune cells that contribute to the inflammatory response, phagocytosis of debris, and tissue repair after injury. We have previously reported that both microglia and MDMs transition from proinflammatory to reparative phenotypes over days after an intracerebral hemorrhage (ICH). However, their individual functional properties in the brain remain largely unknown. Here we characterized the differences between microglia and MDMs and further elucidate their distinct activation states and functional contributions to the pathophysiology and recovery after ICH.
Methods: Autologous blood injection was used to model ICH in mice. Longitudinal transcriptomic analyses on isolated microglia and MDMs from mice at days 1, 3, 7 and 10 after ICH and naive controls identified core transcriptional programs that distinguish these cells. Imaging flow cytometry and in vivo phagocytosis assays were used to study phagocytic ability of microglia and MDMs. Antigen presentation was evaluated by ovalbumin-OTII CD4 T-cell proliferation assays with bone marrow–derived macrophages and primary microglia cultures.
Results: MDMs had higher phagocytic activity and higher erythrophagocytosis in the ICH brain. Differential gene expression revealed distinct transcriptional signatures in the MDMs and microglia after ICH. MDMs had higher expression of MHCII (major histocompatibility complex class II) genes than microglia at all time points and greater ability to induce antigen-specific T-cell proliferation. Conclusions: The different ontogeny of microglia and MDMs lead to divergent responses and functions in the inflamed brain as these 2 cell populations differ in phagocytic functions and antigen-presenting capabilities in the brain after ICH.

Entities:  

Keywords:  cerebral hemorrhage; immunity, innate; macrophages; microglia; phagocytosis

Mesh:

Year:  2021        PMID: 33840225      PMCID: PMC8085165          DOI: 10.1161/STROKEAHA.120.032196

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  46 in total

1.  Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells.

Authors:  Jianpeng Sheng; Christiane Ruedl; Klaus Karjalainen
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

2.  Flow cytometric analysis of inflammatory cells in ischemic rat brain.

Authors:  Marilena Campanella; Clara Sciorati; Glauco Tarozzo; Massimiliano Beltramo
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

3.  Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats.

Authors:  K Becker; D Kindrick; J Relton; J Harlan; R Winn
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

4.  Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.

Authors:  Xiurong Zhao; Guanghua Sun; Jie Zhang; Roger Strong; Weitao Song; Nicole Gonzales; James C Grotta; Jaroslaw Aronowski
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

5.  Identification of a unique TGF-β-dependent molecular and functional signature in microglia.

Authors:  Oleg Butovsky; Mark P Jedrychowski; Craig S Moore; Ron Cialic; Amanda J Lanser; Galina Gabriely; Thomas Koeglsperger; Ben Dake; Pauline M Wu; Camille E Doykan; Zain Fanek; Liping Liu; Zhuoxun Chen; Jeffrey D Rothstein; Richard M Ransohoff; Steven P Gygi; Jack P Antel; Howard L Weiner
Journal:  Nat Neurosci       Date:  2013-12-08       Impact factor: 24.884

6.  Targeted two-photon chemical apoptotic ablation of defined cell types in vivo.

Authors:  Robert A Hill; Eyiyemisi C Damisah; Fuyi Chen; Alex C Kwan; Jaime Grutzendler
Journal:  Nat Commun       Date:  2017-06-16       Impact factor: 14.919

7.  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Authors:  E Baixeras; B Huard; C Miossec; S Jitsukawa; M Martin; T Hercend; C Auffray; F Triebel; D Piatier-Tonneau
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

8.  The microglial sensome revealed by direct RNA sequencing.

Authors:  Suzanne E Hickman; Nathan D Kingery; Toshiro K Ohsumi; Mark L Borowsky; Li-chong Wang; Terry K Means; Joseph El Khoury
Journal:  Nat Neurosci       Date:  2013-10-27       Impact factor: 24.884

9.  Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes-Activation and Age-Related Effects.

Authors:  Srikant Rangaraju; Syed Ali Raza; Noel Xiang'An Li; Ranjita Betarbet; Eric B Dammer; Duc Duong; James J Lah; Nicholas T Seyfried; Allan I Levey
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

10.  Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia.

Authors:  James C Cronk; Anthony J Filiano; Antoine Louveau; Ioana Marin; Rachel Marsh; Emily Ji; Dylan H Goldman; Igor Smirnov; Nicholas Geraci; Scott Acton; Christopher C Overall; Jonathan Kipnis
Journal:  J Exp Med       Date:  2018-04-11       Impact factor: 14.307

View more
  2 in total

Review 1.  The Fate of Erythrocytes after Cerebral Hemorrhage.

Authors:  Fan Xia; Richard F Keep; Fenghui Ye; Katherine G Holste; Shu Wan; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2022-01-23       Impact factor: 6.800

Review 2.  Role of Eryptosis in Hemorrhagic Stroke.

Authors:  Mei Fang; Fan Xia; Yuqi Chen; Yuke Shen; Lu Ma; Chao You; Chuanyuan Tao; Xin Hu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.